HIPEC combined with camrelizumab, paclitaxel and S-1 for conversion therapy in patients with advanced gastric cancer with peritoneal metastasis: A prospective phase II clinical study.
Authors: Yian Du, Yu Pengfei, Zeyao Ye
Published: 2025-05-28
DOI:
10.1200/jco.2025.43.16_suppl.e16017
Source:
Full article
Abstract
e16017